OverviewCJC-1295 is a synthetic peptide analog of Growth Hormone–Releasing Hormone (GHRH) designed to examine pituitary signaling and growth hormone–axis pathways in research settings. Research FocusResearchers utilize CJC-1295 to analyze receptor binding dynamics, GHRH-mediated signaling models, and peptide stability. Mechanism of InterestIts engineered structure supports exploration of extended GHRH receptor activation and downstream biochemical pathways associated with GH-axis signaling. Compliance NoticeFor research only. Not for human consumption.